Finance

Lists
688426:SHA
Jiangsu Cowin Biotech Co Ltd
19,79 CN¥
+1,23%
(+0,24) 1D
16 қаз., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688426...
Open
19,65 CN¥
High
21,10 CN¥
Low
19,28 CN¥
Mkt. cap
2,23 млрд
Avg. vol.
2,08 млн
Volume
2,13 млн
52-wk high
33,67 CN¥
52-wk low
14,42 CN¥
EPS
-0,80 CN¥
No. of employees
732
Open
19,65 CN¥
High
21,10 CN¥
Low
19,28 CN¥
Mkt. cap
2,23 млрд
Avg. vol.
2,08 млн
Volume
2,13 млн
52-wk high
33,67 CN¥
52-wk low
14,42 CN¥
EPS
-0,80 CN¥
No. of employees
732
News stories
From web sources and news partners
About Jiangsu Cowin Biotech Co Ltd
CEO-
Employees732
Founded2007
Headquarters-
Sector-
Websitecwbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
52,46 млн
53,95 млн
59,00 млн
54,02 млн
Cost of goods sold
28,39 млн
40,03 млн
31,17 млн
27,57 млн
Cost of revenue
28,39 млн
40,03 млн
31,17 млн
27,57 млн
Research and development expenses
18,09 млн
18,47 млн
14,95 млн
14,15 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,05 млн
30,93 млн
31,16 млн
32,48 млн
Operating expense
51,11 млн
48,27 млн
46,69 млн
53,49 млн
Total operating expenses
79,50 млн
88,30 млн
77,86 млн
81,05 млн
Operating income
-27,05 млн
-34,35 млн
-18,86 млн
-27,03 млн
Other non operating income
-863,74 м.
531,76 м.
-757,35 м.
665,41 м.
EBT including unusual items
-21,25 млн
-24,68 млн
-17,20 млн
-21,55 млн
EBT excluding unusual items
-23,19 млн
-31,11 млн
-17,68 млн
-26,48 млн
Income tax expense
453,02 м.
8,56 млн
-1,61 млн
-1,51 млн
Effective tax rate
-2,13%
-34,68%
9,34%
7,03%
Other operating expenses
330,76 м.
51,88 мың
-581,03 м.
1,42 млн
Net income
-20,25 млн
-31,25 млн
-15,35 млн
-19,83 млн
Net profit margin
-38,61%
-57,93%
-26,02%
-36,71%
Earnings per share
-
-
-
-
Interest and investment income
4,69 млн
3,86 млн
2,06 млн
1,70 млн
Interest expense
-220,77 м.
-202,67 м.
-127,60 м.
-251,24 м.
Net interest expenses
4,47 млн
3,65 млн
1,94 млн
1,44 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,94 млн
-26,74 млн
-11,25 млн
-19,04 млн
Gain or loss from assets sale
273,75 м.
-243,09 м.
-
-93,35 мың
AI content may include mistakes. Learn more
Google қолданбалары